Objetivo
The safety and efficacy of bone marrow transplantation using donors other than human leucocyte antigen (HLA) identical siblings was investigated. The results of analyses conducted are preliminary. Nonetheless a substantial proportion of leukemia patients were disease free, alive and well following transplantation of HLA incompatible bone marrow donated by family members.
Ámbito científico
Tema(s)
Data not availableConvocatoria de propuestas
Data not availableRégimen de financiación
CSC - Cost-sharing contractsCoordinador
8701 MILWAUKEE
Estados Unidos